...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >NON-HEPATIC HYPERAMMONEMIC COMA: A CASE REPORT
【24h】

NON-HEPATIC HYPERAMMONEMIC COMA: A CASE REPORT

机译:非肝性肝炎昏迷:病例报告

获取原文

摘要

While the most common cause of hyperammonemic (HA) coma is hepatic disorder, other rare etiologies to be considered include congenital causes, drug induced states, portosystemic shunts, and urinary tract infections with urea-splitting organisms. HA usually results from one of the following three mechanisms: A relative excessive nitrogen load on a normal functioning liver via the portal circulation (e.g., parenteral nutrition in a patient with urea cycle defect); ammonia bypassing liver (e.g., congenital vascular malformations, portal hypertension in cirrhotic patients); or from impaired ammonia metabolism. Herein, we describe a case of HA coma secondary to an interplay of multiple psychiatric drugs mainly sodium valproate and probably an added effect by the lithium-induced hypothyroidism/myxedema.
机译:高氨血症(HA)昏迷的最常见原因是肝病,但应考虑的其他罕见病因包括先天性原因,药物诱发状态,门体分流以及尿素分解生物引起的尿路感染。 HA通常是由以下三种机制之一引起的:通过门脉循环(例如,尿素循环缺陷患者的肠胃外营养)对正常运作的肝脏造成相对过量的氮负荷;氨绕过肝脏(例如肝硬化患者先天性血管畸形,门静脉高压症);或氨代谢受损。在本文中,我们描述了继发于多种精神科药物(主要是丙戊酸钠)之间相互作用而继发的HA昏迷情况,并可能是锂诱导的甲状腺功能减退症/粘液性水肿引起的附加作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号